Digital Horizons - Technology Transformation in MS Consultations.
Professor Gavin Giovannoni chairs presentation and discussion with speakers Dr Gillian Ingram, Dr Saúl Reyes, Dr Ide Smets
Agenda
- Neurological consultation evolution, embracing opportunity,
Professor Gavin Giovannoni - Digital integration, learnings from a Welsh neurology service with established virtual practices, Dr Gillian Ingram
- Virtual neurological assessment tools; opportunities and reality, demonstration of a new clinical tool, Dr Ide Smets and Dr Saúl Reyes
- Panel discussion and audience Q&A
Meet the Chairperson:
Professor Gavin Giovannoni
Chair of Neurology at Barts and The London School of Medicine, whose research interests have focused around MS and inflammatory disorders of the central nervous system. Teaching focuses on clinical neurology and neuroimmunology.
Meet the guest speaker:
Dr Gillian Ingram
Consultant Neurologist with a specialist interest in MS at Swansea Bay University Health Board, and Honorary Senior Lecturer at Swansea University. Investigator on several national and international multi-centre clinical trials, ongoing research interests in immunological and epidemiological aspects of MS.
Meet the guest speaker:
Dr Saúl Reyes
Academic Neurologist who specialises in MS and other demyelinating diseases, Department of Neurology, Barts and The Royal London Hospital, London. Works with MS and related disorders research group at Hospital Universitario Fundación Santa Fe de Bogotá, Colombia. Research interests include vaccination in people with MS, neurofilaments and social capital. Currently serves on the scientific steering committee for the Treatment and Research in Multiple Sclerosis online conference (triMS.online).
Meet the guest speaker:
Dr Ide Smets
Academic Neurologist who specialises in MS and other demyelinating diseases, Department of Neurology, Barts and The Royal London Hospital, London. She obtained her PhD at the Catholic University of Leuven, Belgium and demonstrated how genetic MS risk factors shape the immune system. Current research interests are the clinical use of neurofilaments and the role of B cells in MS.
Digital Horizons - Technology Transformation in MS Consultations.
Meet the Chairperson:
Professor Gavin Giovannoni
Chair of Neurology at Barts and The London School of Medicine, whose research interests have focused around MS and inflammatory disorders of the central nervous system. Teaching focuses on clinical neurology and neuroimmunology.
Meet the guest speaker:
Dr Gillian Ingram
Consultant Neurologist with a specialist interest in MS at Swansea Bay University Health Board, and Honorary Senior Lecturer at Swansea University. Investigator on several national and international multi-centre clinical trials, ongoing research interests in immunological and epidemiological aspects of MS.
Meet the guest speaker:
Dr Saúl Reyes
Academic Neurologist who specialises in MS and other demyelinating diseases, Department of Neurology, Barts and The Royal London Hospital, London. Works with MS and related disorders research group at Hospital Universitario Fundación Santa Fe de Bogotá, Colombia. Research interests include vaccination in people with MS, neurofilaments and social capital. Currently serves on the scientific steering committee for the Treatment and Research in Multiple Sclerosis online conference (triMS.online).
Meet the guest speaker:
Dr Ide Smets
Academic Neurologist who specialises in MS and other demyelinating diseases, Department of Neurology, Barts and The Royal London Hospital, London. She obtained her PhD at the Catholic University of Leuven, Belgium and demonstrated how genetic MS risk factors shape the immune system. Current research interests are the clinical use of neurofilaments and the role of B cells in MS.
This meeting has been developed for Healthcare Professionals only from the UK and Ireland.
Adverse events should be reported. For Ireland, reporting forms and information can be found at www.hpra.ie. For the UK, reporting forms and information an be found at https://yellowcard.mhra.gov.uk/ or via the Yellow Card app available from the Apple App Store or Google Play Store. Adverse events should also be reported to Biogen Idec Ltd on 1800 812 719 in Ireland and 0800 008 7401 in the UK.